Skip to main content
. 2016 Mar 6;160(3):141–151. doi: 10.1093/jb/mvw019

Fig. 1.

Fig. 1.

Substrates and analogs tested with IDOLDH. Strong substrates showing specific activity (SA) > 27 nmol·min−1·mg−1 at <20 μM substrate, and weak substrates (SA of 10 to 27 nmol·min−1·mg−1 at between 17 and 31 μM substrate are in the upper and lower left panels, respectively, while poor or non-substrates are in the right panel.